A Clinical Study of JS005 in Patients With Ankylosing Spondylitis
NCT06250062
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
261
Enrollment
OTHER
Sponsor class
Conditions
Ankylosing Spondylitis
Interventions
DRUG:
Recombinant humanized IL-17A Monoclonal Antibody（JS005）
DRUG:
Placebo（JS005）
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Collaborators
[object Object]